We hypothesized that the ratio of the isoforms of Cav-1 to each other differs between normal fibroblasts and CAFs in patients with OSCC and that this shift in the expression of the isoforms in the tumor microenvironment may contribute to tumor development and progression. This evidence concerns the gene CAV1 and neoplasm.